辉瑞液明珠联合托吡卡胺治疗假性近视的临床疗效观察
 |
| 第1页 |
参见附件。
【摘要】 目的 探讨辉瑞液明珠联合托吡卡胺治疗假性近视的科学性及临床应用效果。方法 124眼假性近视眼随机分为两组:A组为辉瑞液明珠联合0. 5%托吡卡胺治疗组;B组为单用0. 5%托吡卡胺治疗组。治疗30 d后比较两组视力及视疲劳症状恢复情况,应用χ2检验分析两组疗效差异。所有统计数据在SPSS11. 0软件包中处理。结果 A组治愈45眼,有效12眼,有效率为91.93%;B组治愈22眼,有效10眼,有效率为51.61%。根据χ2检验,A组优于B组(P<0. 05, χ2=5.68)。结论 辉瑞液明珠联合0. 5%托吡卡胺治疗组其疗效明显优于单纯应用0. 5%托吡卡胺治疗组,其疗效可靠,且在服药期间均未出现任何不良反应,故此法可作为防止假性近视发展成为真性近视的预防性用药。
【关键词】 辉瑞液明珠;0. 5%托吡卡胺;假性近视
Clinical efficacy of Pfizer Lutein combining with Tropicamide in treatment of pseudomyopia
LIU Yuan-bin.Fenyang College of Shanxi Medical University, Shanxi 032200, China
【Abstract】 Objective To explore the scientificity and clinical efficacy of Pfizer Lutein combining with Tropicamide in treatment of pseudomyopia.Methods 124 pseudomyopia eyeswere divided into two groups: A group was given Pfizer Lutein combining with Tropicamide; B group was given 0.5% Tropocamide only.30 days after treatment, recoverence of vision and asthenopia symptom were compared between the two groups and the curative effect differences were analysed by χ2 examination ......
您现在查看是摘要介绍页，详见PDF附件。